tyrosyl-prolyl-leucyl-glycinamide has been researched along with Anochlesia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kastin, AJ; Kostrzewa, RM | 1 |
Hara, C; Kastin, AJ | 1 |
2 other study(ies) available for tyrosyl-prolyl-leucyl-glycinamide and Anochlesia
Article | Year |
---|---|
Tyr-MIF-1 attenuates development of tolerance to spiperone-induced catalepsy in rats.
Topics: Amino Acid Sequence; Animals; Benzazepines; Catalepsy; Drug Administration Schedule; Drug Tolerance; Male; Molecular Sequence Data; Motor Activity; MSH Release-Inhibiting Hormone; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Spiperone; Stereotyped Behavior | 1993 |
Acute administration of MIF-1 or Tyr-MIF-1 inhibits haloperidol-induced catalepsy in rats.
Topics: Animals; Catalepsy; Dose-Response Relationship, Drug; Haloperidol; Male; MSH Release-Inhibiting Hormone; Rats | 1986 |